NA
SRDX

Navellier & Associates’s Surmodics SRDX Stock Holding History

Navellier & Associates’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-45,944
Closed -$919K – 302
2013
Q2 		$919K Buy
+45,944
New +$1.15M 0.04% 118

Other funds holding SRDX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Navellier & Associates's SRDX Position: Q3 2013 in Review

Navellier & Associates sold out of Surmodics (SRDX) in Q3 2013, closing a stake of 45,944 shares — an estimated $919K sold.

Navellier & Associates first reported a position in SRDX in Q2 2013 and held it in 1 quarter. The position peaked at $919K in Q2 2013. 114 funds tracked by Wall St. Rank hold SRDX as of Q3 2013.

  • Navellier & Associates reported no remaining Surmodics position as of Q3 2013 after selling out during the quarter.
  • Navellier & Associates sold 45,944 Surmodics shares in Q3 2013, an estimated $919K.
  • Navellier & Associates first reported a position in Surmodics in Q2 2013 and held it in 1 quarter.
  • Navellier & Associates's Surmodics position peaked at $919K in Q2 2013.
  • 114 funds tracked by Wall St. Rank held Surmodics as of Q3 2013.

Based on Navellier & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.